Literature DB >> 26831875

[Role and management of cancer clinical database in the application of gastric cancer precision medicine].

Yuanfang Li, Zhiwei Zhou1.   

Abstract

Precision medicine is a new medical concept and medical model, which is based on personalized medicine, rapid progress of genome sequencing technology and cross application of biological information and big data science. Precision medicine improves the diagnosis and treatment of gastric cancer to provide more convenience through more profound analyses of characteristics, pathogenesis and other core issues in gastric cancer. Cancer clinical database is important to promote the development of precision medicine. Therefore, it is necessary to pay close attention to the construction and management of the database. The clinical database of Sun Yat-sen University Cancer Center is composed of medical record database, blood specimen bank, tissue bank and medical imaging database. In order to ensure the good quality of the database, the design and management of the database should follow the strict standard operation procedure(SOP) model. Data sharing is an important way to improve medical research in the era of medical big data. The construction and management of clinical database must also be strengthened and innovated.

Entities:  

Mesh:

Year:  2016        PMID: 26831875

Source DB:  PubMed          Journal:  Zhonghua Wei Chang Wai Ke Za Zhi        ISSN: 1671-0274


  2 in total

Review 1.  Preoperative Chemotherapy for Gastric Cancer: Personal Interventions and Precision Medicine.

Authors:  Wei Xu; Maneesh K Beeharry; Wentao Liu; Min Yan; Zhenggang Zhu
Journal:  Biomed Res Int       Date:  2016-12-25       Impact factor: 3.411

Review 2.  Optimization of perioperative approaches for advanced and late stages of gastric cancer: clinical proposal based on literature evidence, personal experience, and ongoing trials and research.

Authors:  Maneesh Kumarsing Beeharry; Tian Qi Zhang; Wen Tao Liu; Zhu Zheng Gang
Journal:  World J Surg Oncol       Date:  2020-03-09       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.